ISIN | IE00BKY80S73 |
---|---|
Valorennummer | 110725523 |
Bloomberg Global ID | |
Fondsname | New Capital Healthcare Disruptors Fund CHF O Acc |
Fondsanbieter |
EFG - New Capital
EFG Asset Management (UK) Ltd Park House, 116 Park Street London, W1K 6AP, United Kingdom Telefon: +44 207 173 8011 E-Mail: enquiries@newcapital.com |
Fondsanbieter | EFG - New Capital |
Vertreter in der Schweiz |
CACEIS (Switzerland) SA Nyon Telefon: +41 22 360 94 00 |
Distributor(en) |
EFG Bank AG Zürich |
Anlagekategorie | Obligationenfonds |
EFC-Kategorie | |
Anteilskategorie | Accumulation |
Domizilland | Irland |
Konditionen bei der Ausgabe | keine Ausgabekommission und/oder Gebühren zugunsten des Fonds (Ausgabe erfolgt zum Inventarwert) |
Konditionen bei der Rücknahme | Keine Rücknahmekommission und/oder Gebühren zugunsten des Fonds (Rücknahme erfolgt zum Inventarwert) |
Investment-Strategie *** | The investment objective of the Sub-Fund is to achieve capital appreciation through investment in a portfolio of equity securities. In order to achieve its investment objective, the Sub-Fund will invest in equities issued by US companies listed or traded on Recognised Markets in the United States such as the NASDAQ, the New York Stock Exchange, the American Stock Exchange, the Chicago Mercantile Exchange and the Chicago Board of Trade across all market capitalizations. The Sub-Fund may invest up to a maximum of 20% of the Net Asset Value in non-US companies including up to 10% of its assets in securities of emerging market issuers. |
Besonderheiten |
Aktueller Preis * | 74.52 CHF | 03.04.2025 |
---|---|---|
Vorheriger Preis * | 76.85 CHF | 02.04.2025 |
52 Wochen Hoch * | 89.18 CHF | 05.02.2025 |
52 Wochen Tief * | 74.52 CHF | 03.04.2025 |
NAV * | 74.52 CHF | 03.04.2025 |
Ausgabepreis * | ||
Rücknahmepreis * | ||
Schlusskurs * | ||
Indikativer Minimalpreis | ||
Fondsvermögen *** | 48'896'272 | |
Anteilsklassevermögen *** | 3'420'938 | |
Trading Information SIX |
YTD-Performance | -8.10% |
31.12.2024 - 03.04.2025
31.12.2024 03.04.2025 |
---|---|---|
1 Monat | -8.19% |
03.03.2025 - 03.04.2025
03.03.2025 03.04.2025 |
3 Monate | -9.52% |
03.01.2025 - 03.04.2025
03.01.2025 03.04.2025 |
6 Monate | -11.93% |
03.10.2024 - 03.04.2025
03.10.2024 03.04.2025 |
1 Jahr | -11.75% |
03.04.2024 - 03.04.2025
03.04.2024 03.04.2025 |
2 Jahre | -3.45% |
03.04.2023 - 03.04.2025
03.04.2023 03.04.2025 |
3 Jahre | -19.36% |
04.04.2022 - 03.04.2025
04.04.2022 03.04.2025 |
5 Jahre | -25.48% |
18.05.2021 - 03.04.2025
18.05.2021 03.04.2025 |
Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
argenx SE ADR | 5.78% | |
---|---|---|
Eli Lilly and Co | 5.43% | |
Natera Inc | 5.25% | |
Veeva Systems Inc Class A | 4.97% | |
Doximity Inc Class A | 4.62% | |
Halozyme Therapeutics Inc | 4.60% | |
Intuitive Surgical Inc | 4.56% | |
Alnylam Pharmaceuticals Inc | 4.31% | |
Stryker Corp | 4.30% | |
IDEXX Laboratories Inc | 3.96% | |
Letzte Daten-Aktualisierung | 31.03.2025 |
TER | 0.0176% |
---|---|
Datum TER | 30.06.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.50% |
Ongoing Charges *** | 1.78% |
SRRI ***
|
|
Datum SRRI *** |